Wordt geladen...
Corporations, high-stakes biomedical research, and research misconduct: yes they can (and sometimes do)
Science has long been vulnerable to research misconduct (RM). Biomedical sciences, with vast financial stakes, carry heightened temptations. However, RM is standardly seen as an undertaking of individual scientists, not as something that could be committed by an organization such as a corporation or...
Bewaard in:
| Gepubliceerd in: | J Law Biosci |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247552/ https://ncbi.nlm.nih.gov/pubmed/34221435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jlb/lsab014 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|